The inaugural Cell Therapy Durability Response Summit is the only industry networking forum dedicated to the #1 challenge of the field: durability.
The summit will be held in Boston, Massachusetts from 22-23 August and there are over 23 speakers confirmed to give talks at the event. Speakers come from companies including Abbvie, Editas Medicine, Be Bipharma and many more! These talks will cover:
- Target Selection and receptor design
- Enhancing activity and persistence in the immunosuppressive tumor microenvironment
- Genetic Engineering and synthetic biology
- Moving beyond CAR-αβT and CAR-NK cells to generate durable responses
You can expect to meet researchers from cell therapy biotechs, representatives from pharmaceutical companies in the cell therapy space, academic experts and R&D solution providers, giving you the perfect chance to speak with experts in the industry.
Get the PDF agenda to find out more: https://hubs.ly/Q01dn9cL0
Event Venue: Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115, United States
Event Date: 22-23 August 2022
Event website: https://celltherapydurability.com/events/cell-therapy-durability-response-summit-usa-2022
Event Organizer: Kisaco Research
Contact number:+44 (0)20 3696 2920
Email ID: laura.hobson@kisacoresearch.com
